Infasurf Suspension
Product Images NDC 61938-456

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Infasurf (NDC 61938-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ony Biotech Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Onybiotech Infasurf 3 mL Label Rev0218

Infasurf® is a medication administered through intratracheal suspension. It is sterile and non-pyrogenic, and it is not meant for injection. It should be stored between 2°-8°C (36°-46°F) and protected from light. Prior to use, it should be resuspended and any unused portions should be discarded. The recommended dosage is 3 mL of Infasurf per kg of body weight. Each mL of suspension contains 35 mg of phospholipids and 0.7 mg of protein. This medication is made by ONY Biotech Inc. in Amherst, NY. Please refer to the package insert for further information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.